Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CHAD THERAPEUTICS INC (CTU)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-08Mar-31-08Dec-31-07Sep-30-07Jun-30-07Mar-31-07Dec-31-06Sep-30-06
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
    Other     11.7  19.921.5
Revenues    10.411.713.519.019.921.5
            Revenue growth    -48.1%-45.6%-38.4%-15.1%-11.8%-6.9%
Cost of goods sold    7.89.310.013.714.214.8
Gross profit    2.62.53.55.35.76.8
            Gross margin    24.9%21.1%25.8%27.9%28.8%31.5%
Selling, general and administrative    4.13.94.25.36.56.6
Research and development    1.01.00.9 1.41.5
EBITDA   [+]  -3.7-3.7-2.8 -1.7-0.9
            EBITDA margin    -35.4%-31.3%-20.7%-11.4%-8.8%-4.0%
Depreciation    0.20.20.3 0.40.4
EBITA    -3.9-3.9-3.0-2.4-2.1-1.3
            EBITA margin    -37.5%-33.3%-22.5%-12.9%-10.7%-5.9%
Amortization of intangibles    0.00.00.10.00.00.0
EBIT   [+]  -3.9-3.9-3.1-2.5-2.2-1.3
            EBIT margin    -37.9%-33.6%-23.2%-13.1%-10.9%-6.0%
Interest expense, net   [+]  0.20.10.0-0.1  
Other income (expense), net       0.00.00.0
Pre-tax income    -4.2-4.1-3.1-2.4-2.1-1.3
Income taxes    1.41.11.11.0-0.8-0.4
            Tax rate    -34.3%-27.9%  37.8%33.3%
Net income    -6.1-5.6-4.6-3.4-1.3-0.8
            Net margin    -58.6%-48.0%-34.0%-18.0%-6.6%-3.9%
   
Basic EPS   [+]  ($0.56)($0.52)($0.41)($0.34)($0.13)($0.08)
Diluted EPS   [+]  ($0.56)($0.52)($0.41)($0.34)($0.13)($0.08)
   
Shares outstanding (basic)   [+]  10.210.210.210.210.210.2
Shares outstanding (diluted)   [+]  10.210.210.210.210.210.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy